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Non-Standard Abbreviations:
CD, Crohn’s disease; COPD, Chronic Obstructive Pulmonary Disease; fMLF (N-Formyl-Met-
Leu-Phe); GNA, Galanthus Nivalis Lectin; IEC, intestinal epithelial cell; IBD, Inflammatory 
Bowel Disease; La-B, Latrunculin B; Lex, Lewis X MMR, (Macrophage Mannose Receptor) 
PHA-E, Phaseolus Vulgaris erythroagglutinin; PMN, Polymorphonuclear neutrophils; sLea, 
sialyl Lewis A; sLec, sialyl Lewis c;TEpM, Transepithelial Migration; (UC) Ulcerative colitis; 
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Abstract
Polymorphonuclear neutrophils (PMN) play a critical role in the innate immune response 
to invading pathogens. However, dysregulated mucosal trafficking of PMN and associated 
epithelial tissue damage is a pathological hallmark of numerous inflammatory conditions 
including inflammatory bowel disease. The glycoprotein CD11b/CD18 plays a well described 
role in regulating PMN transepithelial migration and PMN inflammatory functions. Previous 
studies have demonstrated that targeting of the N-linked glycan Lewis X on CD11b blocks PMN 
transepithelial migration (TEpM). Given evidence of glycosylation dependent regulation of 
CD11b/CD18 function, we performed MALDI TOF Mass Spectrometry (MS) analyses on 
CD11b/CD18 purified from human PMN.  Unusual glycan epitopes identified on CD11b/CD18 
included high Mannose oligosaccharides recognized by the Galanthus Nivalis (GNA) lectin and 
biantennary galactosylated N-glycans recognized by the Phaseolus Vulgaris erythroagglutinin 
(PHA-E) lectin. Importantly, we show that selective targeting of glycans on CD11b with such 
lectins results in altered intracellular signaling events that inhibit TEpM and differentially affect 
key PMN inflammatory functions including phagocytosis, superoxide release and apoptosis. 
Taken together, these data demonstrate that discrete glycan motifs expressed on CD11b/CD18 
such as biantennary galactose could represent novel targets for selective manipulation of CD11b 
function and reduction of PMN associated tissue damage in chronic inflammatory diseases. 
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Introduction
Polymorphonuclear neutrophils (PMN) are the first innate immune cells to respond to 
infection or tissue injury and they are essential for successful elimination of invading pathogens 
(1). In addition to their role as professional phagocytes, PMN contribute to wound healing and 
restitution of mucosal homeostasis at later stages of an inflammatory response (2). However, 
under conditions of non-resolving inflammation, ongoing PMN migration and release of toxic 
anti-microbial agents directly contributes to host tissue damage. As such, dysregulated influx of 
activated PMN into mucosal tissues is a pathological hallmark of a number of chronic 
inflammatory diseases including inflammatory bowel disease (IBD) and chronic obstructive 
pulmonary disease COPD (3-5).
Trafficking of PMN to sites of infection or mucosal inflammation begins with migration 
out of the microcirculation. Initial PMN rolling on vascular endothelium is mediated by 
reversible adhesion interactions between Selectins and their glycosylated ligands including P 
Selectin glycoprotein ligand 1 (6, 7). PMN arrest during rolling is triggered by 
chemokines/cytokines and is mediated by binding of PMN CD11a/CD18 2-integrins to 
endothelial expressed immunoglobulin superfamily members such as ICAM-1 and VCAM-1. 
The final step of PMN transendothelial migration involves passage to the interstitium through 
paracellular or less common transcellular routes (8, 9). In the case of epithelial lined organs, 
including the lungs, intestine and urinary tract, following extravasation PMN trafficking to sites 
of infection/inflammation requires migration across a polarized epithelial barrier. In contrast to 
PMN transendothelial migration, the steps that mediate PMN transepithelial migration (TEpM) 
have not been nearly as well characterized. However, previous studies have identified several 
epithelial expressed glycoproteins that are important for PMN TEpM including Intracellular 
adhesion molecule 1 (ICAM-1), CD55, CD47 and CD44v6 (10-13). Furthermore, there is 
evidence for selective involvement of multiple Lewis family glycans including Sialyl Lewis A 
(14), Lewis A (15) and Lewis X (16) in regulation of TEpM and other PMN effector functions in 
the intestine. In terms of leukocyte expressed adhesion molecules,  multiple lines of evidence 
have shown that a major PMN receptor that regulates TEpM is the highly glycosylated 2-
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In addition to being critical for PMN TEpM, CD11b/CD18 also regulates other important 
PMN inflammatory functions including phagocytosis, respiratory burst activity, degranulation 
and apoptosis (22, 23). Interestingly, regulation of these key PMN functions via glycan binding 
protein (lectin) activity has also been previously described. Specifically, studies have 
demonstrated that concavalin A binding to mannose and wheat germ agglutinin (WGA) binding 
to N-Acetylglucosamine activates human PMN, inducing phagocytosis and respiratory burst 
responses (24, 25). The importance of glycan mediated binding events in stimulating PMN 
immune function is further highlighted by leukocyte adhesion deficiency II, a genetic disorder 
resulting in defective glycosylation of Selectin ligands. Individuals with this fucosylation 
deficiency have recurrent bacterial infections, persistent peripheral blood leukocytosis as well as 
severe mental and growth retardation (26). Furthermore altered expression of glycans has been 
implicated in disease pathogenesis during murine colitis and in the inflamed mucosa of humans 
with active inflammatory bowel disease (14, 27-29).
While CD11b/CD18 is known to be a key regulator of PMN inflammatory effector 
functions, the role of specific CD11b/CD18 glycans in mediating PMN inflammatory activity is 
poorly understood. In this study, we performed tandem MALDI-TOF Mass Spectrometry (MS) 
to generate, for the first time, a complete profile of the N-linked glycans on human PMN 
CD11b/CD18. N-glycan analysis of CD11b/CD18 revealed a surprising lack of sialylation. 
Unusual glycan epitopes identified on CD11b/CD18 included high Mannose oligosaccharides 
recognized by the Galanthus Nivalis (GNA) lectin and the Macrophage Mannose Receptor 
(MMR) as well as biantennary galactosylated glycans recognized by the Phaseolus Vulgaris 
erythroagglutinin (PHA-E) lectin. Furthermore, we show that selective targeting of these specific 
CD11b expressed glycans with lectins results in intracellular signaling events that differentially 
regulate key PMN inflammatory functions including chemotaxis, TEpM, phagocytosis, 
superoxide generation and apoptosis. These data highlight the functional significance of CD11b 
glycans as targets to regulate PMN inflammatory effector functions and ameliorate PMN 
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Materials and Methods
Antibodies, Lectins and Reagents
Galanthus Nivalis (GNA), Phaseolus Vulgaris erythroagglutinin (PHA-E), Wheat Germ 
Agglutinin (WGA) Lectins and protein free blocking solution were purchased from Vector Labs 
(Burlingame, CA). 1m FITC-conjugated carboxylate FluoSpheres (505/5150) were purchased 
from Molecular Probes (Carlsbad, CA). N-Formyl-L-methionyl-Leucyl-L-phenylalanine 
(fMLF), Leukotriene B4 (LTB4), Latrunculin B, Cytochrome c from bovine heart and 
Superoxide dismutase (SOD) were purchased from Sigma-Aldrich (St. Louis, MO). BCECF, 
AM (2',7'-Bis-(2-Carboxyethyl)-5-(and-6)-Carboxyfluorescein, Acetoxymethyl Ester) and 
fluorescent counting beads were purchased from ThermoFisher Scientific (Waltham, MA). The 
functionally inhibitory anti-CD11b antibody CBRM1/29 has been characterized elsewhere (30). 
Antibodies against CD18 were purchased from Abcam (Cambridge, UK). PNGaseF was 
purchased from New England Biolabs (Ipswich, MA). Recombinant human Mannose 
Macrophage Receptor (CD206) was purchased from R&D Systems (Minneapolis, MN). Mouse 
Fc block (CD16/CD32), anti-CD45 PerCP (Clone30-F11) and FITC conjugated human anti-
CD11a mAbs were purchased from BD Bioscience (San Jose, CA). Anti-CD11b PE (clone 
M1/70) was purchased from eBioscience (Waltham, MA). Anti-Ly6G Alexa Fluor 647 (clone 
1A8) was purchased from Biolegend (San Diego, CA). Signaling antibodies for immunoblotting 
were published from Cell Signaling Technologies (Danvers, MA). 
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Cultures of T84 (19) and SKCO15 IECs (31) were grown as previously described. PMN 
were isolated from whole blood obtained from normal human volunteers, with approval from the 
University of Michigan Institutional Review Board on human subjects, using a previously 
described Polymorphprep density gradient centrifugation technique (11).  PMN isolated in this 
way were 97% pure and >95% viable and were used for all assays within 2 hours of blood draw. 
Colonoids were generated from biopsies of normal human colonic mucosa as previously 
described (32, 33). All human colon sample collection was performed in accordance with the 
University of Michigan Institutional Review Board regulations. Isolated colonoids were re-
suspended in matrigel and cultured in growth media containing Wnt3a, R-Spondin and Noggin 
which was replaced every other day. Colonoid cultures were maintained via passaging once per 
week. To generate 2D monolayers, colonoids grown as described above were spun out of 
matrigel and dissociated into a single cell suspension using Trypsin/EDTA as described 
previously (34). Following one day of culture in complete growth media, cells were switched to 
differentiation media (growth media minus Wnt3a, R-Spondin and with a 50% reduction in 
Noggin) for 4-5 days of differentiation into monolayers of differentiated colonic epithelium.
Immunoblotting and Protein Purification
PMN cell lysates for immunoblotting were prepared with the following lysis buffer 
(20mM Tris pH 7.5, 150mM NaCl, 1mM EDTA, 1% TX-100, 1mM Na3VO4, and 1mM PMSF) 
supplemented with 10% mammalian tissue protease inhibitor cocktail (Sigma-Aldrich, St. Louis, 
MO). PMN cell lysates were boiled in sample buffer under reducing conditions, and then 
subjected to SDS-PAGE followed by transfer to PVDF under standard conditions. Binding of 
biotinylated lectins was detected using HRP conjugated streptavidin. Data are representative of 
PMN isolated from 5 independent healthy donors. N-glycans were removed from CD11b/CD18 
using PNGaseF according to manufacturer’s instructions. Functionally active CD11b/CD18 was 
purified from human PMNs by LM2/1 immunoaffinity chromatography as described previously 
(35, 36).
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10µg of protein (CD11b/CD18 immunopurified from human PMN) was resolved by SDS 
Page gel electrophoresis. Upon staining with CBB, the CD11b/CD18-corresponding bands were 
excised out of the gel, washed with ammonium bicarbonate (AMBIC) and 50% acetonitrile 
(ACN) prior to incubation with 1,4-dithiothreitol (DTT) and iodoacetamide (IAA). The 
DTT/IAA solutions were removed, and the samples were then incubated overnight with trypsin. 
The peptides were recovered from the gel by sequential washes with AMBIC and ACN buffers. 
The N-glycans were subsequently removed with PNGaseF (New England Biolabs) and 
recovered using a C18 Sep-Pak (50 mg) column (Waters). Flow thru and wash fractions 
containing the N-glycans, were pooled and lyophilized
Permethylation of N-glycans
N-glycans were permethylated by incubation with iodomethane in a NaOH/DMSO 
solution under vigorous shaking. Permethylated N-glycans were then recovered in chloroform 
and washed with MilliQ water. The chloroform fraction, containing permethylated N-glycans 
was evaporated, the dried N-glycans re-suspended in a 50% methanol solution and loaded onto a 
C18 Sep-Pak (50 mg). Finally, N-glycans were eluted with 50% ACN and lyophilized
MALDI-TOF data acquisition
Dried permethylated N-glycans were re-suspended in a 50% methanol solution and 
spotted on a MALDI target plate (polished steel, Bruker Daltonics) with 2,5-dihydroxybenzoic 
acid as matrix. MS data was acquired on a Bruker UltraFlex II MALDI-TOF Mass Spectrometer 
instrument. MS signals matching an N-glycan composition were considered for further analysis. 
Subsequent MS post-data acquisition analysis were made using mMass (37).
PMN Transmigration and Chemotaxis Assay
For transmigration experiments, IECs were grown on collagen-coated, permeable 0.33-
cm2 polycarbonate filters (3m pore size; Costar Corp.) and effects of 10g/ml indicated lectins 
or glycan binding proteins on  PMN TEpM in the physiologically relevant basolateral to apical 
direction quantified as described previously (11, 14, 19). For migration assays PMN were 
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adherent to IEC monolayers following basolateral to apical migration were quantified as follows. 
Following completion of migration T84 monolayers were removed and transferred to new 24 
well tissue culture plates containing 500l HBSS+. Plates were spun at low speed (50 x g) for 5 
minutes and detachment of PMN from the apical surface of epithelial cells was quantified by 
MPO assay as described above. For PMN chemotaxis assays, PMN were incubated with 10g/ml 
indicated antibodies/lectins before migration across collagen-coated, permeable 0.33-cm2 
polycarbonate filters to 100nm fMLF was assessed by measurement of MPO as described above.
CD11b/CD18 T84 IEC Adhesion Assay
Functionally active human CD11b/CD18 (purified to homogeneity as described above) 
was added to Nunc maxisorp flat bottomed 96 well plates at a concentration of 5g/ml for 
protein immobilization as previously described (30, 38). 
Immunofluorescence detection of glycan expression.
Immunofluorescent labeling of IECs was achieved as follows. Confluent T84 monolayers 
were fixed and permeabilized in absolute ethanol and subsequently blocked with protein free 
blocking buffer. Following blocking, monolayers were incubated with 5g/ml Alexa Fluor 555 
conjugated anti-ZO-1 mAb (ZO1-1A12), FITC conjugated lectins and Hoechst stain for nuclear 
detection. All images were captured using a Leica SP8 confocal microscope system.
Flow Cytometry and Phagocytosis assay
For flow cytometry analyses, non-stimulated PMN or PMN stimulated with 10nM 
fMLF(human) or 1 M fMLF (mouse) were incubated with 10g/ml of FITC conjugated lectins 
or antibodies. Flow cytometric analysis was carried out using an ACEA NovoCyte Flow 
Cytometer. For phagocytosis assays, PMN were incubated with 10g/ml relevant lectins 
(unconjugated) and FITC conjugated FluoSpheres at a ratio of 1:100 (PMN:FluoSpheres) in the 
presence of 10nM fMLF for 30 minutes at 37oC. Uptake of FluoSpheres by PMN was assessed 
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PMNs were isolated as described above and incubated with relevant antibodies at a 
concentration of 10g/ml for 30 mins at 37oC. To induce degranulation PMNs were treated with 
1.25M Latrunculin B (La-B) for 5 mins followed by stimulation with 5M fMLF for 10 mins. 
As a positive control for inhibition of degranulation, PMN were incubated with the anti-Lex mAb 
H198. Following indicated incubations, PMNs were washed with PBS-EDTA and stained with 
antibodies against CD63 and CD66b (as indicators of primary and specific granule contents), and 
then fixed overnight using BD LyseFix PhosFlow before data acquisition using an LSRII. Data 
are representative of PMN isolated from 3-5 independent donors.
Assay of PMN superoxide generation
For measurement of oxidative burst 0.5 x 106 human PMN were treated with 10g/ml 
indicated lectin or vehicle control for 15 minutes at 37oC. Following lectin incubations, cells 
were spun down, washed and re-suspended in HBSS+ containing 100M cytochrome C as 
described previously (39). As a control for each sample a duplicate well containing 250U/ml 
superoxide dismutase (SOD) was also prepared. Reduction of cytochrome c following addition 
of 500nM fMLF was assessed by measuring changes in absorbance at 550nm at indicated 
timepoints up to 20 minutes using a Cytation 5 imaging reader (Biotek, Winooski, VT). 
PMN aggregation assay
To determine the direct effect of lectin binding human PMN were incubated for 15 
minutes at 37oC with 10g/ml GNA, PHA-E or WGA in HBSS+ before levels of aggregation 
were captured using a Zeiss Axiovert 200M microscope at 10 x magnification.
PMN Apoptosis assay
For PMN apoptosis assays, PMN were incubated with 10g/ml indicated glycan binding 
protein (or HBSS+ only as a control) for 15 minutes at 37oC. Following treatments PMN were 
stained for markers of apoptosis according to manufacturer’s instructions using an apoptosis 
detection kit (BD Bioscience, Franklin Lakes, NJ). Briefly PMN were washed and resuspended 
in Annexin V buffer containing 7AAD and incubated for 30 mins at 37oC before flow cytometric 
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Isolation and purification of murine neutrophils.
Neutrophils were isolated from bone marrow extracted from the femur and tibias of WT 
C57BL6 mice using an EasySep kit from Stem Cell Technologies as previously described (40, 
41). For isolation of circulating murine PMN, WT C57BL6 mice were anesthetized with 
isoflurane before peripheral blood removal by cardiac puncture followed by cervical dislocation. 
Red blood cells were lysed using Ack buffer and PMN were then isolated by density 
centrifugation using a histopaque gradient (1:1 mix of histopaque 1119 and histopaque 1077).
Quantification of effect of CD11b/CD18 glycan targeting on PMN TEpM in vivo.
In vivo experiments were performed using C57BL/6 WT mice (8-12 weeks, both sexes) 
which were maintained under standard conditions with 12-hour day/night cycles and ad libitium 
access to food and water. To quantify PMN TEpM in vivo a recently published proximal colon 
protocol was used (17).  Briefly, mice were pretreated with proinflammatory cytokines before a 
2cm loop of vascularized proximal colon was injected with 1nM LTB4 and migration or 
epithelial association of PMN quantified by flow cytometry.  
Immunoblot analysis of signaling pathways in human neutrophils
For human PMN signaling western blotting, PMN were isolated as described above and 
stimulated with 10ug/ml indicated lectin for 5,15,30,45 and 60 minutes at 37oC. Following 
stimulation PMN were lysed by the addition of an equal volume of 2X loading buffer and boiled. 
Western blotting was performed as described above using primary antibodies from Cell 
Signaling Technologies (Total Syk #131985, p-Syk Tyr323 #2715S, Total Erk1/2 #4695S, p-
Erk1/2 Thr202/Tyr204 #4307T, Total P38 MAPK #86905, p-P38 MAPK Thr180/Try182 
#4511).
Statistics 
Statistical differences were determined by one way ANOVA with Tukey post-hoc testing 
using PRISM 8, Graphpad software, Inc. Values are expressed as the mean and SEM from at 
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All experimental procedures involving animals were conducted in accordance with NIH 
guidelines and protocols approved by the University Committee on Use and Care of Animals at 
University of Michigan. All experiments using human blood were conducted in accordance with 
NIH guidelines approved by the Institutional Review Board of the University of Michigan 
Medical School. Written informed consent was received from participants prior to inclusion in 
the study.
Results
Purification and MALDI-TOF Mass Spectrometry (MS) analysis of human CD11b/CD18
In order to determine its glycosylation profile and study consequences of CD11b glycan 
targeting, CD11b/CD18 was purified from human PMN. SDS PAGE and Coomassie staining of 
isolated CD11b/CD18 revealed purification to homogeneity with two protein staining bands 
consistent in size with CD11b (Mw~170 kDa) and CD18 (Mw~85 kDa, Fig. 1A). Western 
blotting with anti-CD11b and anti-CD18 mAbs confirmed the presence of both integrin subunits 
in the purified material (Fig. 1B). Treatment of CD11b/CD18 with PNGaseF resulted in 
enhanced electrophoretic mobility, consistent with N- linked glycosylation of both  2-integrin 
subunits (Fig. 1C). 
Given the observed presence of N-linked glycosylation on CD11b/CD18, we performed 
glycometric analyses of human CD11b and CD18 using matrix-assisted laser 
desorption/ionization time-of-flight (MALDI-TOF) Mass Spectrometry (MS). As CD18 is a 
subunit common to multiple integrins including CD11b/CD18, CD11a/CD18 and CD11c/CD18, 
we initially focused on N-linked glycans of the unique CD11b subunit. MS analysis of CD11b 
revealed a surprising lack of sialylation (Fig. 1D). This lack of glycans terminating in sialic acid 
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analysis of human neutrophil total cell lysates 
(http://www.functionalglycomics.org/glycomics/common/jsp/samples 
/searchSample.jsp?templateKey=2&12=CellType&operation=refine&2=205). The most 
abundantly expressed N-linked glycan on CD11b, representing approximately 22% of total N-
glycans (blue shading, supplemental Table 1), was predicted to be an uncommon terminal high 
mannose type oligosaccharide (Man9GlcNAc2, m/z 2396.3, black box Fig. 1D).  These complex 
glycans with non-reducing end mannose residues represent ligands for Galanthus Nivalis lectin 
(GNA) (42) and mannose macrophage receptor (MMR)(43, 44). In addition, more common 
mannose containing glycans were detected on CD11b (Fig. 1D, green boxes). Several 
biantennary galactosylated N-glycans (blue boxes, Fig. 1D) accounting for approximately 18% 
of all predicted N-glycans on CD11b (yellow shading, Supplemental table 1) were also 
identified. These galactosylated N-glycans represent high affinity ligands for the legume lectin 
phytohemagglutinin from Phaseolus vulgaris (PHA-E) (45). 
In addition, Lewis family glycans including Sialyl Lewis X and Lewis A/X (Fig. 1D, red 
boxes) were also identified. In contrast to the glycan profile for CD11b, analysis of the N-linked 
glycans expressed on CD18 revealed a less diverse glycosylation profile (Supplemental Fig. 1). 
However, the glycan ligands for PHA-E (Fig. 1D, blue box) as well as Lex were also detected on 
CD18. In addition, the high mannose glycan recognized by GNA (the most abundant N-glycan 
detected on CD11b) was also predicted to be present (Supplemental Fig. 1, black box). However, 
this glycan represented only 1.8% of the total N-glycans predicted for CD18 compared to a 
relative abundance of 22% of the N-glycans on CD11b (Supplemental table 1).
 
Increase in surface expression of N-Glycans recognized by PHA-E and GNA in stimulated 
human PMN
Western blotting of purified CD11b/CD18 with biotinylated PHA-E lectin confirmed the 
expression of biantennary galactosylated glycans on both CD11b and CD18 (Fig. 2A). 
Immunoblotting with a biotinylated lectin against high mannose glycans (biotinylated GNA) 
confirmed abundant expression of these glycans on CD11b (Mw~ 170 kDa, Fig. 2A). In contrast 
there was little to no detection of these oligosaccharides on the CD18 subunit (band absent at 
85kDa, Fig. 2A) consistent with the low relative abundance predicted for these glycans on CD18 
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was also confirmed by western blotting. Furthermore, consistent with the Mass Spec data, sLex 
expression was restricted to CD11b (Fig. 2A). 
Treatment of CD11b/CD18 with PNGaseF to remove N-glycans completely ablated 
binding of GNA and PHA-E demonstrating that the glycans recognized by these lectins are 
exclusively N-glycan-linked on human PMN CD11b/CD18 (Fig. 2B). Similar to immunoblotting 
of purified CD11b/CD18, western blotting of total PMN lysates with biotinylated PHA-E 
revealed two heavily glycosylated bands consistent in size with CD11b and CD18 (Fig. 2C), 
suggesting restricted expression of these galactosylated biantennary glycans to CD11b/CD18 in 
human PMN. Immunoblotting of human PMN cell lysates with biotinylated GNA revealed a 
protein consistent in size with CD11b (Mw~170 kDa) and confirmed the lack of expression of 
this high mannose oligosaccharide on CD18 (no band observed at 85 kDa). An additional band at 
approximately 65 kDa was also observed following western blotting of human PMN lysates with 
biotinylated GNA. 
CD11b/CD18 is a known activation marker for human neutrophils with increased surface 
expression of this integrin observed following stimulation with the bacterial N-formylated 
tripeptide N-Formyl-Met-Leu-Phe (fMLF). Consistent with CD11b glycan expression, flow 
cytometry analysis of human neutrophils revealed a significant increase in surface expression of 
glycan ligands for GNA and PHA-E following stimulation with fMLF (**, p < 0.01) or LTB4 (*, 
p<0.05). This increase in surface expression was paralleled by the expected increase in surface 
expression of CD11b following stimulation with fMLF (***, p < 0.001) or LTB4 (**, p < 0.01, 
Fig. 2D). In contrast there was no increase in surface expression of CD11a downstream of PMN 
stimulation with fMLF or LTB4, consistent with GNA and PHA-E selectively recognizing 
glycans expressed on CD11b but not CD11a.
Targeting of CD11b glycans with PHA-E blocks PMN TEpM and PMN detachment from 
the apical epithelial surface.
Having confirmed expression of specific N-linked glycans on CD11b, we then 
determined the effect of targeting these glycans on key PMN inflammatory functions including 
PMN trafficking across intestinal epithelium. As can be seen in Fig. 3A targeting of biantennary 
galactosylated glycans with 10g/ml PHA-E significantly inhibited PMN TEpM in the 
physiologically relevant basolateral to apical direction (***, p >0.001). In contrast, treatment of 
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oligosaccharides, had no effect on PMN TEpM to fMLF (Fig. 3A). For initial migration assays, 
PMN were incubated with lectins after application to the basolateral epithelial surface (top 
chamber of transwell). The effect of lectins on PMN binding to the apical epithelial surface 
(bottom chamber of transwell) was also determined. As shown in Fig. 3B, apical application of 
10g/ml PHA-E significantly inhibited PMN TEpM (***, p>0.001). To determine if the 
observed decrease in transmigration was due to inhibition of PMN detachment from the apical 
epithelial surface, numbers of PMN that had reached but not detached from the apical epithelial 
surface following treatment with lectins were quantified.  As shown in Fig. 3C, apical PHA-E 
treatment increased the number of apically adherent PMN by about 50% (***, p>0.001). As was 
shown for basolateral PMN incubation, apical application of GNA or MMR had no effect on 
PMN TEpM or PMN apical epithelial adhesion. 
 Taken together, these data suggest that targeting of glycans on CD11b with PHA-E 
blocks PMN TEpM though alteration of PMN binding interactions with both basolateral and 
apical epithelial ligands. Immunoblotting of T84 IEC lysates with biotinylated lectins was 
performed in order to determine if the glycans recognized by PHA-E, GNA and MMR were also 
expressed by human intestinal epithelial cells. Fig. 3D demonstrates expression of a high 
molecular weight (Mr~ 170 kDa) as well as lower molecular weight proteins (Mr ~ 100 kDa) 
recognized by biotinylated PHA-E. Epithelial proteins (Mr ~ 80kDa and 130kDa) were also 
detected by GNA. Glycoproteins of similar size were also detected by PHA-E and GNA in 
SKCO15 cells (a second IEC line) as well as in differentiated 2D colonoid monolayers (non-
transformed human colonic epithelial cells, Fig. 3D). Having demonstrated epithelial expression 
of glycans recognized by PHA-E and GNA in IECs, we then identified the cellular localization 
of these glycans by immunofluorescence staining (IF). IF analysis of T84 monolayers (Fig. 3E) 
revealed apical and basolateral expression of biantennary galactosylated glycans recognized by 
PHA-E in addition to some co-localization with the junctional protein ZO-1. In contrast 
expression of high mannose glycans recognized by GNA was restricted to the apical epithelial 
surface.
Given the epithelial expression of glycans recognized by PHA-E and GNA in human 
intestinal epithelial cell lines and primary human colon derived cells, we next determined the 
effect of CD11b glycan targeting on PMN migration in a system with no intestinal epithelial 
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assessed. Similar to effects on TEpM, incubation of PMN with PHA-E significantly inhibited 
PMN chemotaxis (Fig. 3F, ***, p > 0.001), while treatment with GNA and MMR had no effect 
on transfilter migration of PMN. To determine if inhibition of PMN TEpM and chemotaxis by 
PHA-E was the result of lectin induced PMN aggregation, PMN were treated with 10g/ml 
PHA-E and GNA and visualized by light microscopy. Incubation of PMN with PHA-E or GNA 
did not result in significant levels of aggregation compared to cells incubated with a known 
agglutinating lectin WGA (Supplemental Fig. 2) demonstrating that PHA-E induced inhibition of 
PMN migration is not the result of PMN aggregation. Next, the effect of glycan targeting on T84 
IEC adhesion to immobilized CD11b/CD18 was measured. Fig. 3G demonstrates that incubation 
with PHA-E increased the level of T84 adherence to CD11b/CD18. As can be seen, addition of 
10g/ml PHA-E resulted in a 25% increase in adherent epithelial cells when compared with non-
treated, GNA treated or MMR treated cells (***, p > 0.001). As expected, addition of a 
functionally inhibitory anti-CD11b mAb (CBRM1/29) significantly reduced adhesion of T84 
IECs to CD11b (***, p<0.001).
Targeting of CD11b/CD18 glycans regulates PMN phagocytosis, ROS production and 
apoptosis but not degranulation.
Given the effects of CD11b glycan targeting on PMN TEpM, the potential role of CD11b 
glycans in regulating other important PMN inflammatory functions was assessed. Flow 
cytometric analyses demonstrated that engagement of the most abundantly expressed CD11b 
high mannose glycans by 10g/ml GNA or MMR significantly decreased the uptake of 
fluorescent microspheres (fluospheres) by PMN (*, p > 0.05, **, p > 0.01, Fig. 4A, B, D). By 
contrast, targeting CD11b glycans with 10g/ml PHA-E significantly increased PMN fluosphere 
phagocytosis (**, p > 0.01, Fig. 4C, D). Taken together, these data suggest differential regulation 
of PMN phagocytosis upon ligation of specific CD11b glycans. Effects of CD11b glycan 
targeting on PMN degranulation in response to Latrunculin B and fMLF stimulation was also 
assessed. As a positive control for inhibition of degranulation, PMN were incubated with 
antibodies against Lex (16). As can be seen in Supplemental figure 3 incubation of PMN with 
10g/ml PHA-E, GNA or MMR did not reduce La-B and fMLF induced increases in surface 
expression of markers of specific (CD66b) and azurophilic granules (CD63). In contrast ligation 
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degranulation markers (CD66b and CD63).  Taken together these data suggest that targeting of 
discrete CD11b glycans differentially regulates PMN phagocytosis while having little effect on 
mobilization of granules to the PMN surface.
In addition to migration and phagocytosis, PMN oxidative burst generation is crucial for 
host defense against invading microbes. Therefore, we examined the effects of CD11b glycan 
engagement on PMN respiratory burst responses. As can be seen from Fig. 4E, incubation of 
human PMN with PHA-E significantly reduced reactive oxygen mediated reduction of 
cytochrome c at 10- and 15-minutes post fMLF stimulation relative to non-lectin treated and 
GNA treated samples (**, p>0.01). However, after 20 minutes of fMLF stimulation there was no 
difference in levels of superoxide production/reduction of cytochrome c in PHA-E treated 
neutrophils compared to controls, suggesting a delay rather than a total block in superoxide 
production downstream of PHA-E targeting of CD11b glycans. In contrast to effects observed 
with PHA-E, targeting of high mannose glycans on CD11b with GNA or MMR had no effect on 
superoxide mediated cytochrome c reduction at any time points measured.
While PMN are traditionally considered relatively short-lived cells, several studies have 
reported delayed PMN apoptosis downstream of CD11b activation. As shown in Fig. 4F,G  
targeting of high Mannose glycans on CD11b with 10g/ml MMR resulted in significantly 
delayed spontaneous PMN apoptosis as measured by quantification of Annexin V positive cells 
(*, p>0.05, Fig. 4F.G). By contrast, targeting of CD11b glycans with 10g/ml PHA-E 
significantly increased the number of Annexin V positive/early apoptotic PMNs (**, p>0.01). 
These results therefore demonstrate differential regulation of PMN apoptosis following targeting 
of high mannose versus biantennary galactosylated glycans on CD11b.
Targeting glycan ligands of PHA-E, GNA expressed by murine PMN in vivo blocks TEpM 
in the proximal colon.
Having demonstrated the expression and functional consequences of targeting human 
CD11b/CD18 glycans, we compared expression of CD11b glycans in human PMN with those on 
murine PMN. Western blotting of lysates from circulating murine PMN revealed a protein 
consistent in size with CD11b (Mw~170kDa) detected by PHA-E and GNA suggesting 
conservation of glycosylation between human and mouse CD11b.  Consistent with glycan 
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significant increase in surface expression of glycan ligands for GNA and PHA-E following 
stimulation with fMLF (**, p < 0.01) or LTB4 (*, p<0.05). This increase in surface expression 
was paralleled by the expected increase in surface expression of CD11b following stimulation 
with fMLF (**, p < 0.01) or LTB4 (**, p < 0.01, Fig. 5B). Expression of glycans recognized by 
GNA and PHA-E was also confirmed by flow cytometry of circulating murine PMN (Fig. 5C). 
Given the similar western blotting profiles observed for human and murine PMN, we tested the 
effect of glycan targeting by GNA and PHA-E on PMN trafficking to the proximal colon in vivo 
using a recently described model (17). Analysis of PMN migration into the lumen of the colon in 
response to a solution of luminally applied LTB4 (1nm) revealed a significant reduction in 
transmigrated PMN in PHA-E treated colon loops compared to non-treated (Ntx) or GNA-treated 
loops after 60 minutes (Fig. 5D, **, p<0.001). In addition, examination of PMN retention in the 
epithelial enriched fraction revealed significantly increased numbers of epithelial associated 
PMN following treatment with PHA-E (Fig. 5E, *, p>0.05) consistent with increased 
CD11b/CD18 mediated PMN epithelial adhesion downstream of PHA-E glycan targeting in vivo.
Targeting of CD11b/CD18 glycans regulates downstream integrin signaling in human PMN
It is well appreciated that CD11b/CD18 mediates PMN functional effects (including 
adhesion, chemotaxis, migration, phagocytosis and superoxide production) through signaling via 
several intracellular kinases including Syk, Erk1/2 and p38MAPK (12, 46, 47). We thus 
investigated the effect of CD11b/CD18 glycan targeting on regulation of these signaling 
pathways in human PMN. As can be seen in Fig. 6A, targeting biantennary galactosylated 
glycans on CD11b/CD18 with PHA-E resulted in robust phosphorylation of Syk [which has been 
shown to positively regulate neutrophil migration (48)] at all time points measured between 5 
and 60 minutes post treatment. By contrast, targeting high mannose glycans on CD11b/CD18 
with MMR or GNA did not result in enhanced phosphorylation of Syk on Tyr323. Since 
phosphorylation at Tyr323 has been reported to decrease Syk kinase activity (49), our finding 
suggests that ligation of CD11b glycans with PHA-E results in negative regulation of Syk 
mediated integrin signaling. In addition to phosphorylation of Syk kinase, robust 
phosphorylation of Erk1/2 was observed downstream of PHA-E treatment. Activation of Erk1/2 
downstream of PHA-E glycan targeting strongly peaked at 5 minutes and gradually diminished 















This article is protected by copyright. All rights reserved
result in Erk1/2 activation. Finally, increased activation of p38MAPK was observed 60 minutes 
after targeting CD11b/CD18 glycans with PHA-E (Fig. 6A,B).  In contrast, decreased 
phosphorylation of p38MAPK was observed 60 minutes after treatment with MMR and GNA 
(Fig. 6A, B).  Taken together these results suggest that selective regulation of 2-integrin 
intracellular signaling may underlie different PMN functional responses observed downstream of 
CD11b glycan targeting (Fig. 6C).
   
Discussion
Mucosal recruitment of PMN represents a double-edged sword in that while neutrophil 
tissue migration is necessary for defense against invading microbes, dysregulated influx of PMN 
is a pathological hallmark of numerous inflammatory diseases. Though the complex mechanisms 
that regulate neutrophil transepithelial migration remain to be fully elucidated, it is well 
established that the 2 integrin CD11b/CD18 is a key regulator of neutrophil TEpM as well as 
PMN inflammatory functions including phagocytosis, superoxide release and degranulation. 
While both subunits of the CD11b/CD18 heterodimer are extensively modified by post 
translational glycosylation, the role of CD11b glycans in regulating PMN function have not been 
well defined. Here we demonstrate that the majority of glycans on neutrophil CD11b are N-
glycan linked consistent with previous studies on human macrophage CD11b (50).  Mass 
Spectrometry analysis of N-glycans on neutrophil CD11b revealed a dramatic lack of sialylation. 
This is in stark contrast to the high levels of sialylation identified by MS analysis of all human 
neutrophil glycoproteins 
(http://www.functionalglycomics.org/glycomics/common/jsp/samples/searchSample.jsp?templat
eKey =2&12=CellType&operation=refine&2=205) suggesting unusual post translational 
glycosylation of human neutrophil CD11b. Given that sialic acid residues frequently mask 
subterminal galactose moieties (51), the observed lack of sialylation is consistent with the 
abundance of glycans terminating with Galactose identified on CD11b. In addition, as terminal 
sialylation and fucosylation are competing processes (52), the low abundance of terminal 
sialyation also corresponds with the high levels of terminally fucosylated glycan structures 
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Expression of unusual glycan signatures including high mannose glycans and biantennary 
galactosylated N-glycans on CD11b was verified using glycan binding proteins/lectins PHA-E, 
GNA and MMR that have complex glycan binding specificities.  Previous studies showing 
altered electrophoretic mobility of CD11b after treatment with Endo H are supportive of the 
observed predominance of high mannose N-linked glycans on human CD11b (50).  Importantly, 
data suggest differential glycosylation between neutrophil expressed 2 integrins. In support of 
this, previous studies have shown that CD11a is modified by glycans that are resistant to N-
glycanase treatment. This therefore suggests a predominance of O-linked (rather than N-linked) 
glycosylation on this member of the 2 integrin family. Furthermore, here we report increased 
surface expression of CD11b (but not CD11a) as well as the glycans recognized by PHA-E and 
GNA in activated PMN. This is consistent with previous studies that show no change in CD11a 
localization following neutrophil stimulation (53, 54) and, is strongly suggestive of the existence 
of glycan determinants on CD11b/CD18 that are not found on other PMN expressed 2 
integrins. 
It is well accepted that mammalian lectins including selectins and galectins play 
important roles in regulating neutrophil extravasation (55). In keeping with this, we show that 
lectin mediated targeting of biantennary galactosylated glycans on CD11b/CD18 blocks PMN 
chemotaxis and PMN TEpM. This is consistent with previous reports demonstrating that 
inhibitory antibodies against CD11b block PMN TEpM in vitro and in vivo (17-19). 
Furthermore, lectin binding to CD11b glycans increased adhesive interactions between T84 
intestinal epithelial cells and PMN CD11b/CD18. Such carbohydrate specific regulation of 
CD11b mediated PMN epithelial adhesion is supported by previous work demonstrating reduced 
adhesion of T84 IECs to CD11b/CD18 mediated by fucose-containing polysaccharides (38). Of 
interest the majority of predicated N-glycosylation sites on CD11b are outside of the I domain 
suggesting that glycan mediated functional effects are I domain independent. In support of 
CD11b glycan mediated binding events not being mediated by the I domain, previous studies 
have shown that the -glucan-binding-lectin-like domain of CD11b [which is important for PMN 
trafficking (56)] is also located outside of the I domain (57). Such CD11b glycan mediated 
regulation of PMN trafficking is in keeping with previous studies which demonstrate that 
targeting Lex glycans on PMN CD11b blocks PMN chemotaxis, TEpM and increases PMN 
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important lectin mediated binding interactions during PMN trafficking. For example, 
Macrophage galactose type lectin 1 deficiency is associated with increased neutrophilia and 
hyperinflammation during gram negative pneumonia (58), while the Galactose binding Bauhinia 
bauhinioides lectin inhibits PMN peritoneal adhesion and migration in response to cytokines  
including TNF- (59). In addition, it has been reported that other lectins including Concavalin A 
and peanut agglutinin lectin stimulate a chemotactic response in human neutrophils (60). 
However, these studies did not identify the specific neutrophil glycoproteins that are the binding 
targets for these lectins.
In addition to mediating neutrophil adhesion, migration and tissue recruitment, CD11b 
participates in many pro-inflammatory PMN functions that are associated with controlling 
infection including phagocytosis and superoxide production (61). Such CD11b/CD18 mediated 
functions are typically triggered by direct integrin ligation. Consistent with CD11b/CD18 being 
the major integrin contributing to phagocytosis in human PMN (62), here we report that targeting 
of PMN CD11b/CD18 sugars with glycan binding proteins differentially regulates PMN 
phagocytosis. Interestingly, specific engagement of biantennary galactosylated N-glycans 
increased the rate of bead uptake by PMN while targeting of high mannose glycans on 
CD11b/CD18 decreased phagocytosis. These findings highlight fine tuning of PMN functional 
responses downstream of selective binding interactions with glycans expressed on CD11b/CD18 
and are analogous to previous studies implicating C-type lectins including Dectin-1, DC-SIGN 
and surfactant proteins A and D in the control of pathogen phagocytosis by neutrophils and 
macrophages (63). Similarly, it has been reported that a Galactose specific plant lectin viscum 
album agglutinin (VAA-I) induces phagocytosis by rabbit PMN (64).
 In addition to effects on phagocytosis, we also observed increased superoxide production 
in PMN after ligation of biantennary galactosylated glycans on CD11b/CD18. These effects were 
transient suggesting a delay rather than a total block in superoxide release and are consistent with 
previous reports demonstrating that induction of ROS by PMN requires signaling by CD11b 
(65). However, despite being the most abundant N-linked glycans on CD11b, targeting of high 
mannose glycans by GNA or MMR had no effect on stimulation of PMN superoxide production 
suggesting glycan specific regulation of PMN ROS release mediated by bisected galactose but 
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Following pathogen destruction mediated by neutrophil antimicrobial effector functions, 
including phagocytosis and ROS production, apoptosis of activated neutrophils is required for 
effective resolution of infection/inflammation. Here we show that targeting of biantennary 
galactosylated glycans on CD11b/CD18 with PHA-E increases spontaneous PMN apoptosis. By 
contrast, targeting of high mannose glycans on CD11b resulted in decreased levels of PMN 
apoptosis. These observations add to previous reports implicating CD11b/CD18-dependent 
signaling in regulating PMN apoptosis (66). Consistent with the observed inhibitory effects 
downstream of targeting high mannose glycans on CD11b, others have shown that the 
macrophage inducible C type lectin (Mincle) reduces PMN apoptosis in a murine model of 
fungal keratitis (67). Other studies have shown that treatment with a galactoside specific plant 
lectin VAA-I can induce spontaneous apoptosis in human neutrophils (64). 
Similar to findings in human PMN, we identified glycans recognized by PHA-E and 
GNA  on CD11b/CD18 from murine PMN. This is consistent with published work 
demonstrating expression of high mannose glycans on murine CD11b (68). In addition, 
consistent with effects on human PMN trafficking, luminal application of the CD11b/CD18 
binding lectin PHA-E inhibited PMN trafficking to the lumen in vivo. Taken together these 
results highlight the broad biological relevance of CD11b/CD18 glycan targeting as a strategy 
for reducing PMN mucosal influx during inflammation. Multiple lines of evidence have shown 
that ligand binding to CD11b/CD18 induces outside-in signaling mediated by specific kinases to 
regulate key PMN functions including migration, phagocytosis and superoxide production (46, 
47, 69). Here we show that targeting of biantennary galactosylated glycans on CD11b decreases 
activation of Syk, consistent with PHA-E-mediated decreases both in PMN migration and 
superoxide production (49, 70, 71). Robust phosphorylation of Erk1/2 was also observed 
downstream of targeting bisected biantennary galactosylated glycans on CD11b, consistent with 
PHA-E-mediated upregulation of PMN phagocytosis and downregulation (72). Previous studies 
have demonstrated that p38MAPK signaling positively regulates PMN phagocytosis and 
apoptosis responses (47, 73, 74). Therefore, differential activation of this kinase is likely 
implicated in the differing phagocytosis and apoptosis responses observed in PMN downstream 
of CD11b glycan targeting. These findings therefore suggest that the type and extent of 
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While PMN have been traditionally thought of as being poorly transcriptionally active 
more recent studies have demonstrated robust de novo synthesis (including upregulation of 
CD11b transcription) in response to inflammatory stimuli (75-77). Therefore, differential PMN 
glycosyltransferase expression patterns during an immune or inflammatory response could result 
in variations in CD11b glycosylation status. As such, there is a need for more systems biology 
analyses to determine how PMN regulation of glycosylation gene expression and enzyme 
activity directly influences integrin glycosylation and downstream function.  CD11b/CD18 is the 
most promiscuous integrin with more than 30 reported ligands including members of the ICAM 
family (35, 78), extracellular matrix components including fibrinogen (79), complement C3 
fragment (80) as well as microbial ligands (81). Given the multitude of reported ligands for 
CD11b/CD18 it is likely that multiple mechanisms (including glycan mediated mechanisms) 
exist by which CD11b recognizes its endogenous binding partners. Furthermore, the 
identification here of high mannose glycans on CD11b suggests that mannose binding proteins 
such as MMR could be endogenous glycan binding ligands for PMN CD11b/CD18.  
Interestingly, the data presented here also suggests an expansion of the potential of plant 
lectins beyond their traditional use as tools to delineate biological processes resulting from 
glycan dependent cell binding. These observations support the biological relevance of plant 
lectins that is further highlighted by studies demonstrating that dietary plant lectins can 
translocate across the intestinal epithelium and act as effective mucosal antigens in the gut (82, 
83). Taken together, these results suggest that highly specific glycosylation modifications present 
on CD11b/CD18 can be selectively targeted to modify different signaling pathways that underlie 
distinct PMN effector functional responses that exacerbate chronic mucosal inflammatory states. 
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Figure Legends.
Figure 1. Identification of N-linked glycans on human CD11b/CD18. CD11b/CD18 purified 
from human PMNs was run on a gel and stained with Coomassie Blue (A) or immunoblotted 
with antibodies against CD11b or CD18 (B). (C) Purified human CD11b/CD18 was treated with 
PNGaseF before immunoblotting for CD11b or CD18. D) N-glycan MALDI-TOF profile for 
human neutrophil CD11b.
Figure 2.  N-glycans recognized by PHA-E and GNA expressed on human CD11b. (A) 
Purified CD11b/CD18 was immunoblotted using biotinylated PHA-E, GNA lectins or antibodies 
against sLex and Lex. (B) Immunoblots showing the CD11b/CD18 glycans recognized by PHA-E 
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with antibodies against CD11b and CD18 or biotinylated PHA-E and GNA lectins. (D) Changes 
in surface expression of CD11b/CD18, CD11a/CD18 and glycans recognized by PHA-E and 
GNA on human PMNs were analyzed by flow cytometry in non-stimulated (Ntx) PMNs and 
PMNs exposed to 100nM FMLF or 10nM LTB4 using FITC conjugated mAbs or lectins. Data 
are mean fluorescent intensities ± SEM (n=5). *, p<0.05, **, p<0.01, ***, p<0.001.
Figure 3. Targeting of CD11b glycans blocks PMN chemotaxis and TEpM and increases 
PMN adhesive interactions. (A) T84 Intestinal epithelial cells were cultured to confluency on 
porous polycarbonate filters (Transwell). Human PMNs were applied to the upper chamber of 
transwell filters, incubated with 10g/ml PHA-E or 10g/ml GNA or 10g/ml MMR and 
induced to migrate into the bottom chamber in response to 100nm fMLF. Migration was 
quantified by MPO assay (n=6 independent donors. ***, p<0.001). Effect of addition of 10g/ml 
PHA-E, 10g/ml GNA or 10g/ml MMR to the apical epithelial surface on PMN TEpM (B) and 
PMN adherence to the apical epithelial surface (C). (D) Expression of glycans recognized by 
PHA-E and GNA by immunoblotting of whole cell lysates from T84 IECs, SKCO15 IECs and 
differentiated human colonoids. (E) Fixed and permeabilized T84 IECs were stained with 
10g/ml anti- ZO-1 mAb (in red) and or 10g/ml PHA-E/GNA (in green) and analyzed by 
confocal microscopy. Original magnification x 60, scale bar = 20m. Representative images 
from n=3 experiments are shown en face or in the xz plane of section. (F) PMN chemotaxis was 
quantified by MPO following incubation of human PMN with 10g/ml PHA-E, 10g/ml GNA 
or 10g/ml MMR. Data depict means ± SEM (A-C, G). n=4 independent donors ***, p<0.001. 
(G) CD11b/CD18 was added to Nunc maxisorp plates at a concentration of 5g/ml before 
addition of 2.5 x 105 BCECF labeled T84 IECs treated with 10g/ml indicated lectins (PHA-E, 
GNA, MMR) or blocking CD11b mAb (CBRM1/29). Following washing CD11b/CD18-IEC 
adhesion was quantified by measuring fluorescence at 485nm. Data shown are % adhesion of 
applied cells and depict means ± SEM (n=4) ***, p<0.001.
Figure. 4. Engagement of CD11b N-linked glycans regulates PMN phagocytosis, ROS 
release and apoptosis. Human PMN were incubated with 10g/ml MMR (A), 10g/ml GNA 
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phagocytosis/uptake was quantified by measuring changes in fluorescence by flow cytometry. 
(D) Data is mean fluorescence intensity normalized to non-treated PMN and is expressed as 
mean ± SEM. n = 3 independent donors *, p<0.05, **, p<0.01. (E) Human PMN were incubated 
with 10g/ml PHA-E, 10g/ml GNA or 10g/ml MMR before treatment with 100M 
cytochrome C. Reduction of cytochrome C in response to 500nM fMLF was measured by 
quantifying changes in absorbance at 550nm at 2,5,10,15 and 20 minutes. Data is fold change in 
absorbance relative to time zero and is expressed as ± SEM. n = 3 independent donors **, 
p<0.01, ***, p<0.001. (F) For apoptosis assays, human PMN were incubated with 10g/ml 
PHA-E, 10g/ml GNA or 10g/ml MMR before assessment of surface expression of Annexin V 
and 7AAD by flow cytometry. Cells negative for Annexin IV and 7AAD were considered non-
apoptotic. Representative flow plots show percentage apoptotic PMN under the defined 
conditions. (G) Quantification of data from flow plots. All Annexin-V positive cells were 
considered early apoptotic neutrophils. Data is expressed as mean ± SEM. n = 4 independent 
donors *, p<0.05, **, p<0.01.
Figure 5. Glycan ligands of PHA-E, GNA expressed by murine PMN and can be targeted to 
block PMN TEpM into the proximal colon. (A) Lysates from circulating murine PMN were 
immunoblotted with anti-CD11b, anti-CD18 mAbs or biotinylated PHA-E, GNA lectins. (B) 
Changes in surface expression of CD11b/CD18 and glycans recognized by PHA-E and GNA on 
murine PMNs were analyzed by flow cytometry in non-stimulated (Ntx) PMNs and PMNs 
exposed to 1M FMLF, or 10nM LTB4 using FITC conjugated mAbs or lectins. Data are mean 
fluorescent intensities ± SEM (n=3, *, p<0.05, **, p<0.01). (C) PMN in whole blood isolated 
from WT C57BL/6 mice were stained with FITC conjugated GNA and PHA-E and analyzed by 
flow cytometry. (D) Number of PMN recruited into the lumen of proximal colon loops following 
luminal injection of PHA-E or GNA. Data are mean ± SEM (n=3 independent experiments, **, 
p<0.01). (E) Number of PMN in epithelial enriched fractions after luminal injection of PHA-E or 
GNA. Data are means ± SEM (n=2 independent experiments. *, p<0.05).
Figure 6. (A) Human neutrophils were stimulated with 10g/ml PHA-E, 10g/ml GNA or 
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p38MAPK.  (B) Densitometry analysis of p38MAPK phosphorylation at 60 minutes of 
stimulation normalized to total p38MAPK levels at the same time point. Values shown are 
relative to Ntx (*, p<0.05, **, p>0.01). (C) Model showing how differential modulation of 
intracellular signaling cascades downstream of CD11b glycan engagement may regulate different 
patterns of PMN functional responses.
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